trending Market Intelligence /marketintelligence/en/news-insights/trending/vzugkt7ebdghfoway0zmaw2 content esgSubNav
In This List

Bellicum Pharmaceuticals names CFO

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

Blog

Essential IR Insights Newsletter - Summer July-August 2023

Blog

Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits


Bellicum Pharmaceuticals names CFO

Bellicum Pharmaceuticals Inc. named Atabak Mokari CFO, effective Dec. 19.

Mokari was CFO and vice president corporate development at IRIDEX Corp., an ophthalmic medical technology company.

Houston-based Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that develops novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders.